Long-term survival of a patient with leptomeningeal involvement by nasopharyngeal carcinoma after treatment with high-dose intravenous methotrexate

被引：8

作者：

Fakhry, Carole ^{[2
]}

Bajaj, Gopal ^{[3
]}

Aygun, Nafi ^{[4
]}

Westra, William ^{[5
]}

Gillison, Maura ^{[1
]}

机构：

[1] Ohio State Univ, Dept Med, Div Hematol & Oncol, Columbus, OH 43210 USA

[2] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA

[3] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD USA

[4] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA

[5] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA

来源：

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2012年 / 34卷 / 02期

关键词：

methotrexate; nasopharyngeal carcinoma; leptomeningeal disease; CNS involvement; high-dose methotrexate; NERVOUS-SYSTEM LYMPHOMA; COMBINED-MODALITY THERAPY; PRIMARY CNS LYMPHOMA; NON-HODGKINS-LYMPHOMA; RADIATION-THERAPY; PHASE-II; MENINGEAL CARCINOMATOSIS; INTRATHECAL CHEMOTHERAPY; NEOPLASTIC MENINGITIS; DEFERRED RADIOTHERAPY;

D O I：

10.1002/hed.21516

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Background. Nasopharyngeal carcinoma with leptomeningeal involvement is rare and typically has poor prognosis. Methods and Results. We present a case report of a patient with nasopharyngeal carcinoma who was treated with high-dose intravenous methotrexate and remains asymptomatic and without clinical evidence of disease 6 years later. Conclusions. Systemic high-dose methotrexate should be evaluated in the treatment of advanced nasopharyngeal carcinoma with central nervous involvement. (C) 2010 Wiley Periodicals, Inc. Head Neck 34: 296-300, 2012

引用

页码：296 / 300

页数：5

共 47 条

[21] Leptomeningeal carcinomatosis [J].

Grossman, SA ;

Krabak, MJ .

CANCER TREATMENT REVIEWS, 1999, 25 (02) :103-119

[22] RANDOMIZED PROSPECTIVE COMPARISON OF INTRAVENTRICULAR METHOTREXATE AND THIOTEPA IN PATIENTS WITH PREVIOUSLY UNTREATED NEOPLASTIC MENINGITIS [J].

GROSSMAN, SA ;

FINKELSTEIN, DM ;

RUCKDESCHEL, JC ;

TRUMP, DL ;

MOYNIHAN, T ;

ETTINGER, DS .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :561-569

[23] Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: Response to therapy and quality of life of patients [J].

Guha-Thakurta, N ;

Damek, D ;

Pollack, C ;

Hochberg, FH .

JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (03) :259-268

[24] TREATMENT OF LEUKEMIA WITH LARGE DOSES OF METHOTREXATE AND FOLINIC ACID - CLINICAL-BIOCHEMICAL CORRELATES [J].

HRYNIUK, WM ;

BERTINO, JR .

JOURNAL OF CLINICAL INVESTIGATION, 1969, 48 (11) :2140-+

[25] Outcome of abducens nerve paralysis in patients with nasopharyngeal carcinoma [J].

Ilhan, Ö ;

Sener, EC ;

Özyar, E .

EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2002, 12 (01) :55-59

[26] DISTANT METASTASES IN NASOPHARYNGEAL CARCINOMA [J].

KHOR, TH ;

TAN, BC ;

CHUA, EJ ;

CHIA, KB .

CLINICAL RADIOLOGY, 1978, 29 (01) :27-30

[27] Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities [J].

Kwong, Yok-Lam ;

Yeung, Dominic Y. M. ;

Chan, Joyce C. W. .

ANNALS OF HEMATOLOGY, 2009, 88 (03) :193-201

[28] Systemic high-dose intravenous methotrexate for central nervous system metastases [J].

Lassman, AB ;

Abrey, LE ;

Shah, GG ;

Panageas, KS ;

Begemann, M ;

Malkin, MG ;

Raizer, RJ .

JOURNAL OF NEURO-ONCOLOGY, 2006, 78 (03) :255-260

[29] Staging of nasopharyngeal carcinoma: Suggestions for improving the current UICC/AJCC staging system [J].

Lee, AWM ;

Au, JSK ;

Teo, PML ;

Leung, TW ;

Chua, DTT ;

Sze, WM ;

Zee, BCY ;

Law, SCK ;

Leung, SF ;

Tung, SY ;

Kwong, DLW ;

Lau, WH .

CLINICAL ONCOLOGY, 2004, 16 (04) :269-276

[30] Cranial nerve involvement in nasopharyngeal carcinoma: Response to radiotherapy and its clinical impact [J].

Li, JC ;

Mayr, NA ;

Yuh, WTC ;

Wang, JZ ;

Jiang, GL .

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2006, 115 (05) :340-345

← 1 2 3 4 5 →